08/05/2024  9:15:50 Diferencia +2.8000 Volumen Bid21:58:00 Ask21:58:00 Capitalización de mecado Dividendo A. P/E Ratio
154.8500EUR +1.84% 150
Volumen de negocios: 23,227.5000
153.5000Volumen de oferta: 140 155.0500Tamaño/ Volumen/ Formato de Ask: 140 19.96 mil millonesEUR 1.42% 23.79

Descripción de negocio

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Consejo de gestión & Consejo de supervisión

CEO
Belén Garijo
Consejo de gestión
Marcus Kuhnert, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Consejo de supervisión
Dr. Wolfgang Büchele, Sascha Held, Alexander Putz, Anne Lange, Christian Raabe, Daniel Thelen, Dietmar Oeter, Gabriele Eismann, Helene von Roeder, Helga Rübsamen-Schaeff, Jürgen Glaser, Michael Kleinemeier, Peter Emanuel Merck, Renate Koehler, Simon Thelen, Birgit Biermann
 

Datos de la empresa

Nombre: Merck KGaA
Dirección: Frankfurter Str. 250,D-64293 Darmstadt
Teléfono: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Industria: Healthcare
Sector: Pharmaceutical Industry
Subsector: Pharmaceuticals
Fin del año financiero: 31/12
Acciones de libre circulación: 66.28%
Fecha de OPI: 20/10/1995

Relación con inversores

Nombre: Constantin Fest
IR teléfono: +49-6151-72-3321
IR-fax: +49-6151-72-91-3321
IR e-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Calendario de la empresa

CW 20 | 15/05/2024 Interim Report 1st Quarter/3 Months
CW 31 | 01/08/2024 Interim Report 2nd Quarter/6 Months
CW 46 | 14/11/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Otros
 
73.64%
BlackRock, Inc.
 
7.43%
Massachusetts Financial Services Company
 
5.06%
Sun Life Financial Inc.
 
4.91%
FMR LLC
 
3.02%
Amundi S.A.
 
2.99%
DWS Investment GmbH
 
2.95%